Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and ...

Panelists discuss how aligning evolving payer policies with real-world oncology practice is key to sustaining timely and ...

Cancer research is evolving, not just in the lab, but in who is leading it. Increasingly, patients, carers and members of the public are stepping into ...

Cancer patients are helping shape research that reflects real lives. This is Patient and Public Involvement – and it’s helping to improve research.

DecisionDx-Melanoma continues to demonstrate strong performance in helping physicians make more informed, risk-aligned ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

Doctors at New York University say two new studies show that they are a significant step closer to making cross-species ...

A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform designed to “scan” the molecular features of each patient’s cancer. Published ...

The findings came from analyses of two national cancer registries. ILC accounts for about 10% of all newly diagnosed breast ...

This article addresses the high failure rates in drug development, offering insights on improving clinical trials through AI ...